COPMiCiv: Anger and Psychotrauma: Data From Military and Civilians

Sponsor
Direction Centrale du Service de Santé des Armées (Other)
Overall Status
Recruiting
CT.gov ID
NCT04518267
Collaborator
(none)
50
4
23.3
12.5
0.5

Study Details

Study Description

Brief Summary

Post-Traumatic Stress Disorder (PTSD) is mainly associated with several emotions such as anger, guilt or shame. By interfering with psychotherapeutic work these emotions can be problematic. When suffering from PTSD, pervasive anger can also have relational consequences. Anger and PTSD are mutually reinforcing: anger can aggravate PTSD symptoms and aggressive behaviours, and conversely, PTSD promotes high levels of anger and aggression. A few explanatory hypotheses have been proposed. In terms of personality factors, anger-treatment may promote the severity of PTSD symptoms and the development of aggressive behaviours. In terms of stressors, exposure to combat and combat-related moral harms could play a role in the relationship between PTSD, anger and traumatic experiences over the course of life. Finally, in clinical terms, in the presence of PTSD, anger and aggressive behaviours may be triggered by substance abuse and depression.

Within the Anglo-Saxon literature, it is recognized that both civilians and military personnel with PTSD exhibit high levels of anger, with a possible predominance among military personnel. While we know that anger management mechanisms can be strongly influenced by cultural aspects and the type of event, there is no data in the French population.

This study proposes to fill in our knowledge of anger-PSTD relationships in the French population and by comparing civilian and military population.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Structured clinical interview
  • Behavioral: Psychological questionnaires

Study Design

Study Type:
Observational
Anticipated Enrollment :
50 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Anger and Psychotrauma: Data From Military and Civilians
Actual Study Start Date :
Sep 21, 2020
Anticipated Primary Completion Date :
Sep 1, 2022
Anticipated Study Completion Date :
Sep 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Civilian group

Participants with civilian status

Behavioral: Structured clinical interview
A structured clinical interview will be performed at enrollment.

Behavioral: Psychological questionnaires
Several psychological questionnaires will be performed at enrollment.

Military group

Participants with military status

Behavioral: Structured clinical interview
A structured clinical interview will be performed at enrollment.

Behavioral: Psychological questionnaires
Several psychological questionnaires will be performed at enrollment.

Outcome Measures

Primary Outcome Measures

  1. Anxiety score [At enrollment]

    Spielberger's State-Trait Anger Expression Inventory-II (STAXI-II) will be used to assess anxiety

  2. PTSD severity score [At enrollment]

    Clinician-Administered Posttraumatic Stress Disorder Scale (CAPS-5) will be used to assess PTSD severity score. CAPS-5 score may range from 0 to 120 with higher scores meaning greater PTSD severity.

  3. Number of life traumatic events [At enrollment]

    Life Event Checklist (LEC) will be used to assess the number of traumatic events experienced by participants throughout their lifetime

Secondary Outcome Measures

  1. Aggressivity score [At enrollment]

    Aggressivity Questionnaire (AQ12) will be used to assess aggressivity score. AQ12 score may range from 6 to 72 with higher scores meaning higher aggressivity levels.

  2. Anger Rumination score [At enrollment]

    Anger Rumination Scale (ARS) will be used to assess anger rumination score. ARS score may range from 19 to 76 with higher scores corresponding to greater levels of anger rumination.

  3. Alcohol consumption score [At enrollment]

    Alcohol Use Identification Test (A.U.D.I.T.) will be used to assess alcohol consumption score Score ≥ 5: at risk use; Score ≥ 8 (7 in women): harmful use; Score ≥ 12 (11 in women): likely alcohol dependence

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
  • To have a PTSD diagnosis

  • To be at least 18 years of age

Exclusion Criteria:
  • To suffer from trauma-related physical condition (including Traumatic Brain Injury)

Contacts and Locations

Locations

Site City State Country Postal Code
1 3ème Centre médical des Armées Lille France 59001
2 Centre Hospitalier de Cadillac Lormont France 33310
3 Centre Hospitalier Léon-Jean Grégory de Thuir Thuir France 66301
4 Groupe Hospitalier Paul Guiraud Villejuif France 94806

Sponsors and Collaborators

  • Direction Centrale du Service de Santé des Armées

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Direction Centrale du Service de Santé des Armées
ClinicalTrials.gov Identifier:
NCT04518267
Other Study ID Numbers:
  • 2019PPRC16
  • 2020-A00507-32
First Posted:
Aug 19, 2020
Last Update Posted:
Mar 9, 2021
Last Verified:
Mar 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 9, 2021